Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.8M Buy
309,626
+8,684
+3% +$1.02M 0.39% 56
2026
Q1
$36.2M Buy
300,942
+84,945
+39% +$9.81M 0.41% 52
2025
Q4
$22.7M Sell
215,997
-9,584
-4% -$900K 0.25% 85
2025
Q3
$18.9M Sell
225,581
-17,082
-7% -$1.41M 0.22% 99
2025
Q2
$19.2M Sell
242,663
-8,890
-4% -$707K 0.24% 101
2025
Q1
$22.6M Sell
251,553
-71,973
-22% -$6.72M 0.32% 78
2024
Q4
$32.2M Buy
323,526
+2,001
+0.6% +$206K 0.44% 53
2024
Q3
$36.5M Buy
321,525
+2,793
+0.9% +$332K 0.5% 47
2024
Q2
$39.5M Sell
318,732
-8,772
-3% -$1.13M 0.57% 42
2024
Q1
$43.2M Sell
327,504
-4,646
-1% -$573K 0.64% 36
2023
Q4
$36.2M Sell
332,150
-16,512
-5% -$1.71M 0.57% 42
2023
Q3
$35.9M Buy
348,662
+1,778
+0.5% +$192K 0.62% 39
2023
Q2
$40M Buy
346,884
+5
+0% +$568 0.68% 37
2023
Q1
$36.9M Sell
346,879
-7,662
-2% -$827K 0.67% 36
2022
Q4
$39.3M Buy
354,541
+20,669
+6% +$2.11M 0.75% 32
2022
Q3
$28.8M Buy
333,872
+5,592
+2% +$499K 0.66% 33
2022
Q2
$30M Buy
328,280
+3,607
+1% +$320K 0.67% 35
2022
Q1
$26.7M Sell
324,673
-5,133
-2% -$405K 0.52% 50
2021
Q4
$25.3M Sell
329,806
-27,303
-8% -$2.17M 0.48% 55
2021
Q3
$26.8M Sell
357,109
-28,229
-7% -$2.15M 0.54% 46
2021
Q2
$30M Sell
385,338
-5,399
-1% -$402K 0.6% 42
2021
Q1
$28.8M Sell
390,737
-97,920
-20% -$7.22M 0.63% 40
2020
Q4
$38.2M Sell
488,657
-24,967
-5% -$1.91M 0.88% 26
2020
Q3
$40.7M Sell
513,624
-21,340
-4% -$1.67M 1.01% 22
2020
Q2
$39.5M Buy
534,964
+71,723
+15% +$5.4M 1.04% 20
2020
Q1
$34M Buy
463,241
+9,074
+2% +$713K 1.18% 17
2019
Q4
$39.4M Sell
454,167
-25,612
-5% -$2.1M 1.08% 19
2019
Q3
$38.6M Buy
479,779
+136,748
+40% +$11M 1.14% 17
2019
Q2
$27.5M Buy
343,031
+7,959
+2% +$609K 0.85% 31
2019
Q1
$26.5M Buy
335,072
+27,230
+9% +$2.04M 0.82% 32
2018
Q4
$22.4M Buy
307,842
+167
+0.1% +$11.8K 0.83% 30
2018
Q3
$20.8M Buy
307,675
+62,460
+25% +$3.98M 0.65% 50
2018
Q2
$14.2M Buy
245,215
+57,353
+31% +$3.24M 0.44% 80
2018
Q1
$9.76M Sell
187,862
-23,767
-11% -$1.28M 0.29% 108
2017
Q4
$11.4M Sell
211,629
-16,427
-7% -$911K 0.36% 96
2017
Q3
$13.9M Sell
228,056
-6,363
-3% -$386K 0.46% 76
2017
Q2
$14.3M Buy
234,419
+12,981
+6% +$790K 0.48% 79
2017
Q1
$13.4M Sell
221,438
-27,988
-11% -$1.7M 0.46% 83
2016
Q4
$14M Sell
249,426
-7,166
-3% -$419K 0.48% 81
2016
Q3
$15.3M Sell
256,592
-7,424
-3% -$434K 0.55% 77
2016
Q2
$14.5M Sell
264,016
-8,582
-3% -$457K 0.54% 77
2016
Q1
$13.8M Sell
272,598
-4,908
-2% -$240K 0.52% 76
2015
Q4
$14M Buy
277,506
+2,335
+0.8% +$118K 0.53% 76
2015
Q3
$13M Buy
275,171
+9,864
+4% +$524K 0.51% 70
2015
Q2
$14.4M Buy
265,307
+2,512
+1% +$141K 0.54% 69
2015
Q1
$14.4M Buy
262,795
+4,553
+2% +$258K 0.54% 64
2014
Q4
$14M Sell
258,242
-21,419
-8% -$1.19M 0.54% 58
2014
Q3
$15.8M Buy
279,661
+23,633
+9% +$1.33M 0.64% 45
2014
Q2
$14.1M Sell
256,028
-5,221
-2% -$285K 0.57% 54
2014
Q1
$14.2M Buy
261,249
+2,236
+0.9% +$116K 0.61% 52
2013
Q4
$12.4M Buy
259,013
+11,319
+5% +$517K 0.55% 58
2013
Q3
$11.3M Sell
247,694
-11,210
-4% -$512K 0.55% 59
2013
Q2
$11.5M Buy
+258,904
New +$11.6M 0.6% 46

Other funds holding MRK

Cullen/Frost Bankers's MRK Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Merck (MRK) stake by 2.9% in Q2 2026, buying an estimated $1.02M and bringing the position to 309,626 shares worth $39.8M. The position accounts for 0.39% of the portfolio, ranked #56.

Cullen/Frost Bankers first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $43.2M in Q1 2024. 1,411 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cullen/Frost Bankers held 309,626 shares of Merck worth $39.8M as of Q2 2026.
  • Cullen/Frost Bankers bought 8,684 Merck shares in Q2 2026, an estimated $1.02M.
  • Merck made up 0.39% of Cullen/Frost Bankers's portfolio in Q2 2026, its #56 holding.
  • Cullen/Frost Bankers first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Cullen/Frost Bankers's Merck position peaked at $43.2M in Q1 2024.
  • 1,411 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.